133 related articles for article (PubMed ID: 20400931)
1. Rituximab as therapy for acute lymphoblastic leukemia.
Thomas DA
Clin Adv Hematol Oncol; 2010 Mar; 8(3):168-71. PubMed ID: 20400931
[No Abstract] [Full Text] [Related]
2. Effectiveness of intrathecal rituximab in patients with acute lymphoblastic leukaemia relapsed to the CNS and resistant to conventional therapy.
Jaime-Pérez JC; Rodríguez-Romo LN; González-Llano O; Chapa-Rodríguez A; Gómez-Almaguer D
Br J Haematol; 2009 Mar; 144(5):794-5. PubMed ID: 19036096
[No Abstract] [Full Text] [Related]
3. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia.
Thomas DA; Faderl S; O'Brien S; Bueso-Ramos C; Cortes J; Garcia-Manero G; Giles FJ; Verstovsek S; Wierda WG; Pierce SA; Shan J; Brandt M; Hagemeister FB; Keating MJ; Cabanillas F; Kantarjian H
Cancer; 2006 Apr; 106(7):1569-80. PubMed ID: 16502413
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody therapy with rituximab for acute lymphoblastic leukemia.
Thomas DA; O'Brien S; Kantarjian HM
Hematol Oncol Clin North Am; 2009 Oct; 23(5):949-71, v. PubMed ID: 19825447
[TBL] [Abstract][Full Text] [Related]
5. New antibodies for acute lymphocytic leukemia.
Advani AS
Clin Adv Hematol Oncol; 2014 Aug; 12(8):547-9. PubMed ID: 25356581
[No Abstract] [Full Text] [Related]
6. Monoclonal antibody-based therapies: a new dawn in the treatment of acute lymphoblastic leukemia.
Kantarjian H; Thomas D; Wayne AS; O'Brien S
J Clin Oncol; 2012 Nov; 30(31):3876-83. PubMed ID: 22891271
[No Abstract] [Full Text] [Related]
7. Early relapse after rituximab chemoimmunotherapy.
Kiss F; Buslig J; Szegedi I; Scholtz B; Kappelmayer J; Kiss C
Pediatr Blood Cancer; 2008 Feb; 50(2):372-5. PubMed ID: 17973316
[TBL] [Abstract][Full Text] [Related]
8. New therapeutic strategies for the treatment of acute lymphoblastic leukaemia.
Pui CH; Jeha S
Nat Rev Drug Discov; 2007 Feb; 6(2):149-65. PubMed ID: 17268486
[TBL] [Abstract][Full Text] [Related]
9. Remission induction with single agent Rituximab in a child with multiply relapsed precursor-B ALL.
Morris ES; Vora A
Br J Haematol; 2007 Oct; 139(2):344-5. PubMed ID: 17897313
[No Abstract] [Full Text] [Related]
10. Precursor B-lymphoblastic transformation of grade I follicle center lymphoma following rituximab therapy.
Follows GA; McVerry A; Owen RG
Am J Clin Pathol; 2000 Dec; 114(6):982-3. PubMed ID: 11338486
[No Abstract] [Full Text] [Related]
11. Treatment with monoclonal antibodies in acute lymphoblastic leukemia: current knowledge and future prospects.
Gökbuget N; Hoelzer D
Ann Hematol; 2004 Apr; 83(4):201-5. PubMed ID: 14648023
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies and complement purged autograft in Burkitt lymphoma and lymphoblastic leukemia.
Favrot M; Philip I; Combaret V; Pavone E; Bouffet E; Biron P; Philip T
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():202-4. PubMed ID: 2713555
[No Abstract] [Full Text] [Related]
13. The efficacy of rituximab in high-grade pediatric B-cell lymphoma/leukemia: a review of available evidence.
Attias D; Weitzman S
Curr Opin Pediatr; 2008 Feb; 20(1):17-22. PubMed ID: 18197034
[TBL] [Abstract][Full Text] [Related]
14. Quest for effective agents to combat T-cell acute lymphoblastic leukemia.
Pui CH
Eur J Cancer; 2005 Jun; 41(9):1243-5. PubMed ID: 15939259
[No Abstract] [Full Text] [Related]
15. Level of tau protein in children treated for acute lymphoblastic leukemia.
Muszyńska-Rosłan K; Krawczuk-Rybak M; Protas PT; Hołownia A
Pediatr Neurol; 2006 May; 34(5):367-71. PubMed ID: 16647996
[TBL] [Abstract][Full Text] [Related]
16. Rituximab plus chemotherapy in children with relapsed or refractory CD20-positive B-cell precursor acute lymphoblastic leukemia.
Claviez A; Eckert C; Seeger K; Schrauder A; Schrappe M; Henze G; von Stackelberg A
Haematologica; 2006 Feb; 91(2):272-3. PubMed ID: 16461321
[TBL] [Abstract][Full Text] [Related]
17. Pediatric regimens for adult acute lymphoblastic leukemia.
Stock W
Clin Adv Hematol Oncol; 2009 Apr; 7(4):244-6. PubMed ID: 19521325
[No Abstract] [Full Text] [Related]
18. New antileukemic agents.
Mantadakis E; Kalmanti M
Pediatr Hematol Oncol; 2003; 20(3):173-85. PubMed ID: 12637214
[TBL] [Abstract][Full Text] [Related]
19. [Management of acute leukemia in adults].
Elonen E
Duodecim; 1989; 105(11):987-93. PubMed ID: 2666099
[No Abstract] [Full Text] [Related]
20. Management of L-asparaginase induced prothrombotic state in acute lymphoblastic leukemia.
Parma M; Belotti D; Pogliani EM
Haematologica; 1996; 81(2):191. PubMed ID: 8641657
[No Abstract] [Full Text] [Related]
[Next] [New Search]
